[1] |
NEWMAN L,ROWLEY J,VANDER HOORN S,et al.Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting[J]. PLoS One,2015,10(12):e0143304.
|
[2] |
World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae[J]. (2016-12-30)[2018-05-05]. .
|
[3] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-S27,CLSI,2017.
|
[4] |
ANDREWS J M,HOWE R A.BSAC standardized disc susceptibility testing method(version 10)[J]. J Antimicrobial Chemother,2011,66(12):2726-2757.
|
[5] |
CHAN P A,ROBINETTE A,MONTGOMERY M,et al.Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae:a review of the literature[J]. Infect Dis Obstet Gynecol,2016,2016:5758387.
|
[6] |
UNEMO M,NICHOLAS R A.Emergence of multidrug-resistant,extensively drug-resistant and untreatable gonorrhea[J]. Future Microbiol,2012,7(12):1401-1422.
|
[7] |
UNEMO M,SHAFER W M.Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century:past,evolution,and future[J]. Clin Microbiol Rev,2014,27(3):587-613.
|
[8] |
NAKAYAMA S,SHIMUTA K,FURUBAYASHI K,et al.New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan[J]. Antimicrob Agents Chemother,2016,60(7):4339-4341.
|
[9] |
UNEMO M,GOLPARIAN D,NICHOLAS R,et al.High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France:novel penA mosaic allele in a successful international clone causes treatment failure[J]. Antimicrob Agents Chemother,2011,56(3):1273-1280.
|
[10] |
CÁMARA J,SERRA J,AYATS J,et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia,Spain[J]. J Antimicrob Chemother,2012,67(8):1858-1860.
|
[11] |
GRAD Y H,HARRIS S R,KIRKCALDY R D, et al. Genomic epidemiology of gonococcal resistance to extended-spectrum cephalosporins,macrolides,and fluoroquinolones in the United States,2000-2013[J]. J Infect Dis,2016,214(10):1579-1587.
|
[12] |
BIGNELL C,UNEMO M,European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults[J]. Int J STD AIDS,2013,24(2):85-92.
|
[13] |
杨阳,吴磊,章楚光,等. 上海地区淋球菌药物敏感性试验和耐药分子机制研究[J]. 中华检验医学杂志,2009,32(10):1173-1175.
|
[14] |
MICAËLO M,GOUBARD A,LA RUCHE G,et al. Molecular epidemiology of penicillinase-producing Neisseria gonorrhoeae isolates in France[J]. Clin Microbiol Infect,2017,23(12):968-973.
|
[15] |
张丽君,王峰,莫俊銮,等. 深圳市头孢曲松低敏淋病奈瑟菌株耐药基因分析[J]. 中华皮肤科杂志,2015,48(10):687-691.
|
[16] |
PENG T,LIN H,LIU Q,et al.Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha,China[J]. J Infect Chemother,2017,23(6):385-389.
|
[17] |
PETOUSIS-HARRIS H,PAYNTER J,MORGAN J,et al.Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand:a retrospective case-control study[J]. Lancet,2017,390(10102):1603-1610.
|
[18] |
SU X H,WANG B X,LE W J,et al.Multidrug-resistant Neisseria gonorrhoeae isolates from Nanjing,China,are sensitive to killing by a novel DNA gyrase inhibitor,ETX0914(AZD0914)[J]. Antimicrob Agents Chemother,2016,60(1):621-623.
|